# Study of Tumor Infiltrating Lymphocytes Following CCRT in the Treatment of Patients With Cervical Carcinoma

> **NCT04443296** · PHASE1 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 10 (estimated)

## Conditions studied

- Cervical Carcinoma

## Interventions

- **DRUG:** CCRT+TIL

## Key facts

- **NCT ID:** NCT04443296
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-12
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2021-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04443296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04443296, "Study of Tumor Infiltrating Lymphocytes Following CCRT in the Treatment of Patients With Cervical Carcinoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04443296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*